{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:20:45Z","timestamp":1770459645719,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HSN272201800004C"],"award-info":[{"award-number":["HSN272201800004C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI110657"],"award-info":[{"award-number":["P01 AI110657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["681137"],"award-info":[{"award-number":["681137"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.xcrm.2022.100635","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:18:04Z","timestamp":1652789884000},"page":"100635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody"],"prefix":"10.1016","volume":"3","author":[{"given":"Behnaz","family":"Heydarchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle S.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia A.","family":"Salazar-Quiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Gonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Grimley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgut E.","family":"Aktepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Wales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit J.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Cupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Rouiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-1726","authenticated-orcid":false,"given":"Damian F.J.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100635_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"Burton","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100635_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12977-018-0433-2","article-title":"Broadly neutralizing antibodies: what is needed to move from a rare event in HIV-1 infection to vaccine efficacy?","volume":"15","author":"Subbaraman","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2022.100635_bib3","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.82.9.2945","article-title":"Antigen-binding specificities of antibodies are primarily determined by seven residues of VH","volume":"82","author":"Ohno","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.xcrm.2022.100635_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0000000000000106","article-title":"Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection","volume":"28","author":"Hraber","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2022.100635_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/COH.0000000000000312","article-title":"Lessons from HIV-1 vaccine efficacy trials","volume":"11","author":"Excler","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2022.100635_bib6","doi-asserted-by":"crossref","first-page":"aac4223","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100635_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006913","article-title":"Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques","volume":"14","author":"Klasse","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2022.100635_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157353","article-title":"Repeated vaccination of cows with HIV Env gp140 during subsequent pregnancies elicits and sustains an enduring strong env-binding and neutralising antibody response","volume":"11","author":"Heydarchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100635_bib9","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1128\/AAC.00453-12","article-title":"Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides","volume":"56","author":"Kramski","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2022.100635_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature23301","article-title":"Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows","volume":"548","author":"Sok","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100635_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.cell.2013.04.049","article-title":"Reshaping antibody diversity","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100635_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/19420862.2016.1270491","article-title":"Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env","volume":"9","author":"Heydarchi","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.xcrm.2022.100635_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2012.10.004","article-title":"Broadly neutralizing antibodies against HIV-1: templates for a vaccine","volume":"435","author":"van Gils","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2022.100635_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.vaccine.2009.10.028","article-title":"Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection","volume":"28","author":"Sellhorn","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2022.100635_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/JVI.75.3.1165-1171.2001","article-title":"Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers","volume":"75","author":"Yang","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.virol.2008.12.009","article-title":"Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins","volume":"385","author":"Dey","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2022.100635_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virol.2004.10.042","article-title":"Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage","volume":"332","author":"Pancera","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2022.100635_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2022.100635_bib19","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by HIV envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100635_bib20","first-page":"11","article-title":"A 35-year review of pre-clinical HIV therapeutics research reported by NIH ChemDB: influences of target discoveries, drug approvals and research funding","volume":"11","author":"Jackson","year":"2020","journal-title":"J.\u00a0AIDS Clin. Res."},{"key":"10.1016\/j.xcrm.2022.100635_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018207","article-title":"An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV","volume":"6","author":"Watkins","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100635_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100635_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100635_bib24","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2022.100635_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"Shingai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100635_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100635_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm.2233","article-title":"Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques","volume":"16","author":"Ng","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2022.100635_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf7962","article-title":"Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies","volume":"1","author":"Stanfield","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100635_bib29","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1038\/ncomms13642","article-title":"Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity","volume":"7","author":"Corcoran","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100635_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/mabs.27105","article-title":"The antibody mining toolbox: an open source tool for the rapid analysis of antibody repertoires","volume":"6","author":"D'Angelo","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.xcrm.2022.100635_bib31","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41467-019-10262-5","article-title":"Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence","volume":"10","author":"Sliepen","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100635_bib32","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01","volume":"85","author":"Li","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib33","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.celrep.2016.07.074","article-title":"Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100635_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2022.100635_bib35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.celrep.2019.03.039","article-title":"The HIV-1 envelope glycoprotein C3\/V4 region Defines a prevalent neutralization epitope following immunization","volume":"27","author":"Lei","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100635_bib36","doi-asserted-by":"crossref","first-page":"e1008753","DOI":"10.1371\/journal.ppat.1008753","article-title":"Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates","volume":"16","author":"Cottrell","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2022.100635_bib37","doi-asserted-by":"crossref","first-page":"108122","DOI":"10.1016\/j.celrep.2020.108122","article-title":"Mapping neutralizing antibody epitope specificities to an HIV Env trimer in immunized and in infected rhesus macaques","volume":"32","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100635_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba0468","article-title":"Structural basis of broad HIV neutralization by a vaccine-induced cow antibody","volume":"6","author":"Stanfield","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2022.100635_bib39","doi-asserted-by":"crossref","first-page":"107488","DOI":"10.1016\/j.celrep.2020.03.052","article-title":"Structure of super-potent antibody CAP256-VRC26.25 in complex with HIV-1 envelope reveals a combined Mode of trimer-apex recognition","volume":"31","author":"Gorman","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100635_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.str.2018.10.007","article-title":"Structural survey of broadly neutralizing antibodies targeting the HIV-1 Env trimer Delineates epitope categories and characteristics of recognition","volume":"27","author":"Chuang","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.xcrm.2022.100635_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency","volume":"90","author":"Doria-Rose","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01187-17","article-title":"Protective efficacy of broadly neutralizing antibodies with incomplete neutralization activity against simian-human immunodeficiency virus in rhesus monkeys","volume":"91","author":"Julg","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005520","article-title":"Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C infection","volume":"12","author":"Wagh","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2022.100635_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100635_bib45","article-title":"Structural basis for broad coronavirus neutralization","author":"Sauer","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100635_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines","volume":"2","author":"Burton","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100635_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tibs.2014.12.006","article-title":"Insights into the trimeric HIV-1 envelope glycoprotein structure","volume":"40","author":"Ward","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.xcrm.2022.100635_bib48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-Pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2022.100635_bib49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1074\/jbc.M117.816447","article-title":"Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous viruses","volume":"293","author":"Wang","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2022.100635_bib50","first-page":"117","article-title":"Quality of life of people living with HIV and AIDS and antiretroviral therapy","volume":"4","author":"Oguntibeju","year":"2012","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.xcrm.2022.100635_bib51","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/v6104095","article-title":"Current perspectives on HIV-1 antiretroviral drug resistance","volume":"6","author":"Iyidogan","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2022.100635_bib52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/00365520500380817","article-title":"ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea","volume":"41","author":"Floren","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2022.100635_bib53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4236\/wja.2015.52012","article-title":"Management of HIV in children using a bovine colostrum-based food product\u2014 an observational field study","volume":"5","author":"Odong","year":"2015","journal-title":"World J. AIDS"},{"key":"10.1016\/j.xcrm.2022.100635_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112047","article-title":"Specificity and effector functions of human RSV-specific IgG from bovine milk","volume":"9","author":"den Hartog","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100635_bib55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1076029606295957","article-title":"Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino","volume":"13","author":"Cesarone","year":"2007","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.xcrm.2022.100635_bib56","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100635_bib57","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.vaccine.2009.06.037","article-title":"Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1","volume":"27","author":"Kang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2022.100635_bib58","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1128\/jvi.69.6.3949-3954.1995","article-title":"Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection","volume":"69","author":"Freed","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib59","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100635_bib60","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/JVI.74.10.4448-4455.2000","article-title":"The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts","volume":"74","author":"Center","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100635_bib61","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1016\/j.vaccine.2009.08.016","article-title":"Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens","volume":"27","author":"Center","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2022.100635_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/v11060507","article-title":"HIV-1-based virus-like particles that Morphologically Resemble mature, infectious HIV-1 virions","volume":"11","author":"Gonelli","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2022.100635_bib63","doi-asserted-by":"crossref","first-page":"18256","DOI":"10.1073\/pnas.1314351110","article-title":"Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation","volume":"110","author":"Ringe","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.xcrm.2022.100635_bib64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2005","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.xcrm.2022.100635_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35383","article-title":"cisTEM, user-friendly software for single-particle image processing","volume":"7","author":"Grant","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2022.100635_bib66","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.xcrm.2022.100635_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:52:18Z","timestamp":1762987938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2666379122001604"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100635","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100635"}}